Image

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Join a study for advanced pancreatic cancer treatment options.

Recruiting
18-75 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)
NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer This study is for patients with advanced pancreatic cancer, a serious disease that starts in the pancreas, an organ that helps digest food. The study will test a combination of treatments called NALIRIFOX, adebrelimab, and PULSAR to see if they are safe and helpful as a first treatment. The study will also look for special markers in the body that might show how well the treatment is working. Key points to consider:
  • The study is for people aged 18-75 with a specific type of pancreatic cancer that cannot be removed by surgery.
  • Participants must have a life expectancy of at least 3 months and be willing to follow study procedures.
  • People with certain health conditions, like severe allergies or active infections, cannot join.
If you join the study, you'll start with a special X-ray test called a CT scan to plan your treatment. Not everyone can join, so doctors will check if you meet the requirements. You'll need to sign a consent form to show you agree to participate.
Print
Study details
    Pancreatic Ductal Adenocarcinoma (PDAC)
    Locally Advanced and Metastatic Pancreatic Cancer

NCT07595172

West China Hospital

30 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.